Perseus Biomics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series C
  • (Upcoming)

  • Latest Deal Amount
  • $15M

  • Investors
  • 3

Perseus Biomics General Information

Description

Developer of microbiome analysis technology designed to monitor the microbiome status and function and quantify its impact on all aspects of human life. The company's technology simplifies, accelerates, and democratizes microbiome analysis to precisely measure the composition and dynamics of the microbiome by uncovering its role in human health and the environment, enabling researchers to access genetic analysis devices to analyze the full genetic makeup of microbiomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Industriepark 6, Bus 3
  • 3300 Tienen
  • Belgium
+32 016
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Monitoring Equipment
Vertical(s)
Corporate Office
  • Industriepark 6, Bus 3
  • 3300 Tienen
  • Belgium
+32 016

Perseus Biomics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perseus Biomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 31-Dec-2025 $15M Upcoming Product In Beta Test
4. Later Stage VC 30-Jun-2024 Completed Product In Beta Test
3. Later Stage VC (Series B) 12-Jan-2024 Completed Startup
2. Grant 16-Jun-2021 $3.04M $2.18M Completed Startup
1. Seed Round 02-Jun-2020 $2.18M $2.18M Completed Startup
To view Perseus Biomics’s complete valuation and funding history, request access »

Perseus Biomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series B
Series A 2,500 $861.25 $861.25 1x $861.25 15.61%
To view Perseus Biomics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Perseus Biomics Patents

Perseus Biomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230250493-A1 Kit and methods for characterizing a virus in a sample Pending 25-Jun-2020
JP-2023530751-A Kits and methods for characterizing viruses in samples Pending 25-Jun-2020

Perseus Biomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Perseus Biomics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Fund Venture Capital Minority
Kindmore Venture Capital Minority
ZEISS Ventures Corporate Venture Capital Minority
To view Perseus Biomics’s complete investors history, request access »

Perseus Biomics FAQs

  • When was Perseus Biomics founded?

    Perseus Biomics was founded in 2016.

  • Where is Perseus Biomics headquartered?

    Perseus Biomics is headquartered in Tienen, Belgium.

  • What is the size of Perseus Biomics?

    Perseus Biomics has 27 total employees.

  • What industry is Perseus Biomics in?

    Perseus Biomics’s primary industry is Biotechnology.

  • Is Perseus Biomics a private or public company?

    Perseus Biomics is a Private company.

  • What is Perseus Biomics’s current revenue?

    The current revenue for Perseus Biomics is .

  • How much funding has Perseus Biomics raised over time?

    Perseus Biomics has raised $13.9M.

  • Who are Perseus Biomics’s investors?

    European Innovation Council Fund, Kindmore, and ZEISS Ventures have invested in Perseus Biomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »